the population for PBA is around 1.5 to 2 million people. Let assume that 10% of the population get the treatment so the revenue for AVNR is around $1B. This estimate does not include off-label uses.
You can bet the bank this will not happen. This comes from someone who didn't like NYTimes article on the drug. I guess there are people who are either very optimistic or delusional.
Market Data 
Markets 
AI
